Cited 0 times in
Incidence, mortality, and risk factors associated with carbapenem-resistant Acinetobacter baumannii bacteremia within 30 days after liver transplantation
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김덕기 | - |
dc.contributor.author | 김명수 | - |
dc.contributor.author | 이재근 | - |
dc.contributor.author | 주동진 | - |
dc.contributor.author | 민은기 | - |
dc.contributor.author | 임승혁 | - |
dc.contributor.author | 최문채 | - |
dc.date.accessioned | 2023-07-12T02:30:13Z | - |
dc.date.available | 2023-07-12T02:30:13Z | - |
dc.date.issued | 2023-05 | - |
dc.identifier.issn | 0902-0063 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/195328 | - |
dc.description.abstract | Carbapenem-resistant Acinetobacter baumannii bacteremia (CRAB-B) is a fatal infectious complication of liver transplantation (LT). This study investigated the incidence, effects, and risk factors associated with CRAB-B during the early post-LT period. Among 1051 eligible LT recipients, 29 patients experienced CRAB-B within 30 days of LT with a cumulative incidence of 2.7%. In the patients with CRAB-B (n = 29) and matched controls (n = 145) by nested-case control design, the cumulative incidence of death on days 5, 10, and 30 from the index date was 58.6%, 65.5%, and 65.5%, and 2.1%, 2.8%, and 4.2%, respectively (p < .001). Pre-transplant MELD (OR 1.11, 95% confidence interval [CI] 1.04-1.19, p = .002), severe encephalopathy (OR 4.62, 95% CI 1.24-18.61, p = .025), donor body mass index (OR .57, 95% CI .41-.75, p < .001), and reoperation (OR 6.40, 95% CI 1.19-36.82, p = .032) were independent risk factors for 30-day CRAB-B. CRAB-B showed extremely high mortality within 30 days after LT, especially within 5 days after its occurrence. Therefore, assessment of risk factors and early detection of CRAB, followed by proper treatment, are necessary to control CRAB-B after LT. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Munksgaard | - |
dc.relation.isPartOf | CLINICAL TRANSPLANTATION | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Acinetobacter Infections* / drug therapy | - |
dc.subject.MESH | Acinetobacter Infections* / epidemiology | - |
dc.subject.MESH | Acinetobacter Infections* / etiology | - |
dc.subject.MESH | Acinetobacter baumannii* | - |
dc.subject.MESH | Anti-Bacterial Agents / therapeutic use | - |
dc.subject.MESH | Bacteremia* / drug therapy | - |
dc.subject.MESH | Bacteremia* / epidemiology | - |
dc.subject.MESH | Bacteremia* / etiology | - |
dc.subject.MESH | Carbapenems / therapeutic use | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Incidence | - |
dc.subject.MESH | Liver Transplantation* / adverse effects | - |
dc.subject.MESH | Risk Factors | - |
dc.title | Incidence, mortality, and risk factors associated with carbapenem-resistant Acinetobacter baumannii bacteremia within 30 days after liver transplantation | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Surgery (외과학교실) | - |
dc.contributor.googleauthor | Eun-Ki Min | - |
dc.contributor.googleauthor | Seung Hyuk Yim | - |
dc.contributor.googleauthor | Mun Chae Choi | - |
dc.contributor.googleauthor | Jae Geun Lee | - |
dc.contributor.googleauthor | Dong Jin Joo | - |
dc.contributor.googleauthor | Myoung Soo Kim | - |
dc.contributor.googleauthor | Deok-Gie Kim | - |
dc.identifier.doi | 10.1111/ctr.14956 | - |
dc.contributor.localId | A05303 | - |
dc.contributor.localId | A00424 | - |
dc.contributor.localId | A03068 | - |
dc.contributor.localId | A03948 | - |
dc.relation.journalcode | J00615 | - |
dc.identifier.eissn | 1399-0012 | - |
dc.identifier.pmid | 36860160 | - |
dc.identifier.url | https://onlinelibrary.wiley.com/doi/10.1111/ctr.14956 | - |
dc.subject.keyword | Acinetobacter baumannii | - |
dc.subject.keyword | carbapenem resistant | - |
dc.subject.keyword | liver transplantation | - |
dc.contributor.alternativeName | Kim, Deok Gie | - |
dc.contributor.affiliatedAuthor | 김덕기 | - |
dc.contributor.affiliatedAuthor | 김명수 | - |
dc.contributor.affiliatedAuthor | 이재근 | - |
dc.contributor.affiliatedAuthor | 주동진 | - |
dc.citation.volume | 37 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | e14956 | - |
dc.identifier.bibliographicCitation | CLINICAL TRANSPLANTATION, Vol.37(5) : e14956, 2023-05 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.